Spotlight
Topic
Brand Insights
Subscribe
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
PEE readership survey
PEE readership survey
Q1
How long have you been a reader of Pharmaceutical Executive Europe?
Since its launch in 2003
2 years
1 year
Less than a year
Q2
Overall, how long do you spend reading an issue of Pharmaceutical Executive Europe?
3 years
6 months
2 years
1 month
1 year
1 week
Q3
How long do you keep your issues of Pharmaceutical Executive Europe?
3 years
6 months
2 years
1 month
1 year
1 week
Q4
Apart from you how many other people read your copy of Pharmaceutical Executive Europe?
5+
2
4
1
3
None
Q5
How often do you read the following sections of Pharmaceutical Executive Europe?
Executive Profile
From the Editor
News & analysis
Brussels report
The Mix
On the Move
Calendar of events
Last Word
Q6
How interested are you in the following sections of Pharmaceutical Executive Europe? (5 = very interested, 1 = not interested)
Executive Profile
From the Editor
News & analysis
Brussels Report
The Mix
On the Move
Calendar of events
Last Word
Q7
How would you rate the following sections of Pharmaceutical Executive Europe?
Executive Profile
From the Editor
News & analysis
Brussels Report
The Mix
On the Move
Calendar of events
Last Word
Q8
How would you rate Pharmaceutical Executive Europe on each of the following criteria?
Range of topics covered
Front cover design
Page layout and design
Relevance to your job
As a strategic business management and marketing publication for the pharma industry
Q9
How much coverage of the following topics would you like to see in future issues?
Brand development
Market research
Marketing strategies
Medical education
Medical communications
Meetings and events
Public relations
New product launch case studies
DTC
Pricing
eDetailing
CRM
Regulatory affairs
Packaging
Marketing technologies
eMarketing
European industry news
RFID
Q10
Are there any other subjects/topics (marketing or non-marketing related) that you would like to see more coverage of in Pharmaceutical Executive Europe?
Q11
Is there anything you would change about Pharmaceutical Executive Europe?
Q12
How many off site meetings do you plan a year?
Q13
Which of the following are you involved in planning?
Sales and training meetings
Meeting planning/site selection
Convention planning
Trade show and exhibition planning
Board meetings
Incentive travel programmes
Other, please specify
Q14
In which of the following locations do you plan to hold meetings?
UK
Switzerland
Germany
Denmark
France
Sweden
Italy
Finland
Spain
Norway
Netherlands
Central and Eastern Europe
Ireland
Q15
What is your annual budget for off site meetings (Euros)?
>1,000,000
50,000 - 100,000
500,000 - 1,000,000
25,000 - 50,000
250,000 - 500,000
<25,000
100,000 - 250,000
Q16
Which of the following products/services related to Medical Education are you involved in purchasing ?
Symposia/educational meetings
Dinner meetings
Facility Selection
Web-enabled CME
Q17
Does your work scope cover the European region?
Yes
No
Q18
Does your work scope cover the Asia Pacific region?
Yes
No
Q19
We are launching a new digital magazine, Pharmaceutical Executive Asia Pacific. Would you like to submit an article for inclusion in this new magazine? (please note, by ticking yes you will be contacted by an editor for further information)
Yes
No
Q20
What is your job function?
Corporate management
Sales management
Brand management
Market research
Marketing management
eMarketing
Project management
CRM
Advertising/PR/Promotion/Media planning
Product Management
Q21
Do you recommend, specify or authorise the purchase of services, equipment or supplies?
I authorise
I specify
I recommend
No involvement
Q22
Name
Q23
Company
Q24
Email address
Q25
Telephone No.
Recent Videos
Related Content
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024Podcast
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024Podcast
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
